Lantheus Holdings, Inc. (LNTH) SEC Filing 8-K Material Event for the period ending Thursday, June 27, 2019

Lantheus Holdings, Inc.

CIK: 1521036 Ticker: LNTH

View differences made from one to another to evaluate Lantheus Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Lantheus Holdings, Inc..


Assess how Lantheus Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Lantheus Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: LNTH
CIK: 1521036
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-187363
Submitted to the SEC: Mon Jul 01 2019 4:05:56 PM EST
Accepted by the SEC: Mon Jul 01 2019
Period: Thursday, June 27, 2019
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Ending Agreement
  2. New Agreement
  3. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: